Mario Ochoa, MD
Family Medicine · Selma, CANPI 1851393615
Payments from drug & device makers
Across 1,304 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$6K
- Corcept Therapeutics$3K
- GSK$2K
- Novo Nordisk$2K
- Amgen$2K
- AbbVie$1K
- plus $13K from 53 others
What the payments were for
- Food & beverage$27,59499%
- Education$3101%
- Gifts$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,964 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 309 | $316,730 |
| OzempicSemaglutide | 282 | $277,179 |
| JardianceEmpagliflozin | 225 | $221,080 |
| KerendiaFinerenone | 187 | $162,515 |
| MounjaroTirzepatide | 95 | $106,315 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 143 | $92,793 |
| XareltoRivaroxaban | 111 | $88,062 |
| HumiraAdalimumab | 12 | $81,641 |
| Xigduo XrDapaglifloz Propaned/Metformin | 96 | $81,384 |
| Diclofenac Sodium | 141 | $79,746 |
| JanuviaSitagliptin Phosphate | 72 | $78,897 |
| EliquisApixaban | 94 | $75,429 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 94 | $68,965 |
| AfrezzaInsulin Regular, Human | 38 | $65,941 |
| TradjentaLinagliptin | 60 | $63,895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $820 | $353,940379 claims |
| Novo NordiskOzempic, Rybelsus, Xultophy 100-3.6 | $1,800 | $345,269335 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $5,770 | $341,591352 claims |
| BayerKerendia | $985 | $162,515187 claims |
| Lilly USA, LLCMounjaro, Trulicity | $1,298 | $161,192146 claims |
| AbbVieHumira, Linzess, Creon | $1,316 | $145,60384 claims |
| MerckJanuvia, Janumet Xr, Janumet, Belsomra | $329 | $138,623153 claims |
| GSKTrelegy Ellipta | $1,904 | $92,793143 claims |
| Johnson & JohnsonXarelto | $1,048 | $88,062111 claims |
| PfizerEliquis | $716 | $75,42994 claims |
| Mannkind CorporationAfrezza | $1,070 | $65,94138 claims |
| AmgenProlia | $1,709 | $53,04231 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Selma
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.